ClinConnect ClinConnect Logo
Search / Trial NCT01438645

ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy

Launched by CHRISTOPHER TESHIMA · Sep 20, 2011

Trial Information

Current as of June 04, 2025

Completed

Keywords

Colonoscopy Colon Cancer Screening

ClinConnect Summary

Summary of Research Proposal

Background:

Colon and rectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality in Canada. Colonoscopy is the preferred screening modality for CRC and has been shown to decrease the likelihood of developing CRC as well as CRC-related mortality, particularly through the detection and removal of potentially pre-cancerous polyps, with the aim of preventing colon cancer, and for the diagnosis of early stage CRC that is more likely to be treatable and result in long-term survival. However, recent evidence suggests that colonoscopy has not bee...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patient 18 years or older.
  • 2. Able to read \& write English.
  • 3. Undergoing colonoscopy at University of Alberta Hospital for any indication.
  • Exclusion Criteria:
  • 1. Colonoscopy performed without prior purgative bowel prep.
  • 2. Patient with active, ongoing lower GI bleeding.
  • 3. Colonoscopy performed to attempt colonic decompression in acute colonic pseudo-obstruction (Ogilvie's syndrome).
  • 4. Colonoscopy for which propofol sedation is required.
  • 5. Inpatient colonoscopy performed by a trainee under staff supervision.
  • 6. Patient with previous colonic surgery.
  • 7. Patient with pacemaker or implantable cardioverter-defibrillator (ICD).

About Christopher Teshima

Christopher Teshima is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the clinical research landscape, Teshima focuses on facilitating innovative studies that adhere to rigorous ethical standards and regulatory compliance. His leadership emphasizes collaboration with healthcare professionals and stakeholders to ensure the successful design, execution, and analysis of clinical trials across various therapeutic areas. By prioritizing patient safety and data integrity, Christopher Teshima strives to contribute to the development of effective therapeutic interventions and enhance the overall quality of care.

Locations

Edmonton, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Christopher W Teshima, MD FRCPC

Principal Investigator

University of Alberta

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials